Copy and paste the "+" delimited list of TIDs into the "Arguments" field of the BTC Company Activity Group page
Dendritic Cell-Based Cancer Immunotherapy
Revolutionizing cancer therapy on a global basis by developing TCR therapies with the potential to treat a wide range of cancer types and patients.
Working on off-the-shelf cellular therapies that may offer the anticancer efficacy of autologous CAR-T treatments without the logistical complexity.
Aduro’s three proprietary technology platforms (Live, Attenuated Double-Deleted Listeria (LADD), STING Pathway Activators, and B-select monoclonal antibodies) have the potential to transform the ...
Advaxis’ Lm Technology uses live, attenuated bioengineered Listeria monocytogenes (Lm) bacteria to stimulate the immune system to view tumor cells as potentially ...
Agios works on cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic diseases and metabolic immuno-oncology.
The company is focused on allergy research, prevention, and diagnosis.
Specific Immunotherapy Allergy Treatment
Alligator is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment ...
The company creates protein-based immunotherapies to treat cancer, autoimmune disorders, and other diseases.
Biologics. Amgen makes several therapeutic drugs that target serious disease. Many are derived from engineered monoclonal antibodies. Some target immune receptors.
Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...
Anaveon is developing a selective IL-2 Receptor Agonist, a type of protein that could therapeutically enhance a patient’s immune system to respond to tumours. In the body, human IL-2 stimulates a ...
Annias Immunotherapeutics, Inc., is a clinical stage company focused on the development of novel immunotherapeutic approaches to treat cancers that contain Cytomegalovirus (CMV).
Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis of autoimmune diseases.
Uses modified antibodies to generate immunotherapeutics.
Arcus’s lead program targets the adenosine pathway, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.
A biopharmaceutical company that focuses on Cardiovascular and Metabolic diseases, Oncology, and Respiratory, Inflammation and Autoimmunity, Infection, Neuroscience and Gastrointestinal diseases, ...
Atara Bio’s programs include T-cell product candidates and molecularly-targeted product candidates.
Avalon GloboCare Corp. is a healthcare management provider and biotechnology developer, dedicated to integrating and managing global healthcare resources, empowering high-impact biomedical ...
Stem Cell Technologies, Fully Human Biologics Manufacturing Cell Lines, Regenerative Medicine, CAR-T Immunotherapy & Cancer Treatment.
A biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.
Develops next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and TCR ...
BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of diseases that affect the Central Nervous System.
BIOSONDA's business is focused on two areas:
1.The research, development, production and commercialization of hemocyanins for the international markets. These are used as carrier proteins ...
The cancer immunotherapy research group is focused on the next generation of T cell engineering and creating a pipeline of T cell product candidates (CAR T cells) to treat a wide variety of liquid ...
A biopharmaceutical company. They discover, develop, and deliver medicines to treat serious disease.
Cell Medica develops therapeutics based on cellular immunotherapy with the aim of improving the treatment of cancer and immune reconstitution following hematopoietic stem cell transplant.
Small Molecules, Biologics, Vaccines, The pipeline is comprised of antibody-based therapies and other protein-based therapeutics that modulate the immune system or directly target tumors.